CID 495796

Nsc668548

Structural Information

Molecular Formula
C30H44N2O
SMILES
CC(CCC1=NC2=CC=CC=C2N1)C3CCC4C3(CCC5C4CCC6C5(CCC(C6)O)C)C
InChI
InChI=1S/C30H44N2O/c1-19(8-13-28-31-26-6-4-5-7-27(26)32-28)23-11-12-24-22-10-9-20-18-21(33)14-16-29(20,2)25(22)15-17-30(23,24)3/h4-7,19-25,33H,8-18H2,1-3H3,(H,31,32)
InChIKey
SPXKHARARHBOQT-UHFFFAOYSA-N
Compound name
17-[4-(1H-benzimidazol-2-yl)butan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

448.34537 Da
Monoisotopic Mass

8.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 449.35265 217.2
[M+Na]+ 471.33459 220.0
[M-H]- 447.33809 219.6
[M+NH4]+ 466.37919 232.9
[M+K]+ 487.30853 210.5
[M+H-H2O]+ 431.34263 206.4
[M+HCOO]- 493.34357 219.4
[M+CH3COO]- 507.35922 221.4
[M+Na-2H]- 469.32004 210.4
[M]+ 448.34482 208.5
[M]- 448.34592 208.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.